🔥🐔 BizChicken 🐔🔥
Companies Similar to Sorrento Therapeutics, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Halozyme Therapeutics, Inc.
ENHANZE drug delivery technology
Halozyme Therapeutics, Inc. is a biopharma technology platform company specializing in enabling subcutaneous delivery of biologics using its patented ENHANZE technology. The company operates in the United States and internationally, offering products such as Hylenex recombinant and developing treatments for various medical conditions including lymphomas and immunodeficiency disorders.
Symbol: HALO
Recent Price: $47.99
Industry: Biotechnology
CEO: Dr. Helen I. Torley M.B. Ch. B., M.R.C.P.
Sector: Healthcare
Employees: 373
Address: 11388 Sorrento Valley Road, San Diego, CA 92121
Phone: 858 794 8889
Last updated: 2024-12-31
ImmunityBio, Inc.
Therapies and Vaccines
Immunity Bio, Inc. is a clinical-stage biotechnology company developing therapies and vaccines to treat cancers and infectious diseases, with a focus on immunotherapy and cell therapy platforms. The company collaborates with several institutes and has multiple therapeutic agents in clinical trials.
Symbol: IBRX
Recent Price: $2.68
Industry: Biotechnology
CEO: Mr. Richard Gerald Adcock
Sector: Healthcare
Employees: 622
Address: 3530 John Hopkins Court, San Diego, CA 92121
Phone: 858 633 0300
Last updated: 2024-12-31
Sangamo Therapeutics, Inc.
ZFP Technology Platform
Sangamo Therapeutics, Inc. is a clinical-stage biotechnology company that develops genomic medicines using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation with a focus on transforming patients' lives.
Contact | About | About | Leadership | Leadership | About | About | About | About | About | About | About | About | About | About | Careers | Vision/Values | DEI | Benefits | About | About | About | About | About | About | About | News | Events | Vision/Values | DEI | Benefits | Careers | Careers | About | About
Symbol: SGMO
Recent Price: $2.34
Industry: Biotechnology
CEO: Dr. Alexander D. Macrae Ch.B, M.B., MRCP, Ph.D.
Sector: Healthcare
Employees: 405
Address: 501 Canal Blvd, Brisbane California, CALIFORNIA 94005
Phone: 510 970 6000
Leadership
- Sandy Macrae, M.B., Ch.B., Ph.D.,
- Gregory Davis, Ph.D., Head of Research and Technology
- Nathalie Dubois-Stringfellow, Ph.D., Chief Development Officer
- Prathyusha Duraibabu, Chief Financial Officer
- Phillip Ramsey, Head of Technical Operations
- Stephanie J. Seiler, CLP, Head of Business Development & Alliance Management
- Louise Wilkie, Global Corporate Communications and Investor Relations
- Scott Willoughby, General Counsel and Corporate Secretary
- H. Stewart Parker, Chair of the Board
- Courtney Beers, Ph.D.,
- Robert Carey,
- Kenneth Hillan, M.B. Ch.B.,
- Margaret (Peg) A. Horn, J.D.,
- John Markels, Ph.D.,
- James R. Meyers,
- Karen Smith, M.D., Ph.D., M.B.A., LLM,
Last updated: 2024-12-31
OmniAb, Inc.
Omni Ab platform
Omni Ab, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company's platform leverages transgenic animals to generate human-like antibodies for therapeutic applications.
Symbol: OABI
Recent Price: $3.56
Industry: Biotechnology
CEO: Mr. Matthew W. Foehr
Sector: Healthcare
Employees: 106
Address: 5980 Horton Street, EmeryVille, CA 94608
Phone: 510 250 7800
Leadership
- Matt Foehr, Chief Executive Officer
- Kurt Gustafson, Chief Financial Officer
- Charles Berkman, JD, Chief Legal Officer and Secretary
- Yasmina Abdiche, PhD, Vice President, Exploratory Research
- Laurel Bernstein, PhD, Vice President, Intellectual Property
- Neil Castle, PhD, Vice President, Biology
- Bob Chen, PhD, Sr. Director, Discovery Systems
- Ellen Collarini, PhD, Sr. Director, Cell Biology
- Bill Harriman, PhD, Sr. Vice President, Antibody Discovery
- Christel Iffland, PhD, Sr. Vice President, Antibody Technologies
- Shelley Izquierdo, PhD, Sr. Director, Antibody Discovery
- Doug Krafte, PhD, Site Head – Durham, North Carolina Sr. Vice President, Ion Channels/Transporters
- Phil Leighton, PhD, Fellow
- Cia McCaffrey, Vice President, People and Talent
- Anil Nair, PhD, Vice President, In Silico Discovery
- Todd Pettingill, CFA, Vice President, Business Development and Strategy
- Chris Silvia, PhD, Vice President, Data Sciences and Corporate IT
- Eric Vajda, PhD, Vice President, Preclinical R&D
- Marie-Cecile van de Lavoir, DVM, PhD, Sr. Vice President, Technical Operations and Genetics
- Donna Ventura, CPA, Sr. Vice President, Corporate Controller
- Carolyn R. Bertozzi, PhD, Board Member
- Sarah Boyce, President and Chief Executive Officer
- Jennifer Cochran, PhD, Board Member
- Matthew W. Foehr, President and Chief Executive Officer
- John Higgins, Board Chair
- Steve Love, Chief Financial Officer
Last updated: 2024-12-31
Oncternal Therapeutics, Inc.
zilovertamab, ONCT-216, ONCT-808, ONCT-534
Oncternal Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in oncology therapies for cancers with significant unmet medical needs, featuring a pipeline that includes the monoclonal antibody zilovertamab and various other targeted treatments.
Symbol: ONCT
Recent Price: $0.53
Industry: Biotechnology
CEO: Dr. James B. Breitmeyer M.D., Ph.D.
Sector: Healthcare
Employees: 27
Address: 12230 El Camino Real, San Diego, CA 92130
Phone: 858 434 1113
Last updated: 2024-12-31
Spyre Therapeutics, Inc.
antibody therapeutics
Spyre Therapeutics, Inc. is a biotechnology company focusing on antibody therapeutics for treating inflammatory bowel disease, using advanced engineering and precision medicine.
Symbol: SYRE
Recent Price: $22.54
Industry: Biotechnology
CEO: Dr. Cameron Turtle DPHIL, Ph.D.
Sector: Healthcare
Employees: 50
Address: 221 Crescent Street, Waltham, MA 02453
Phone: 617 651 5940
Last updated: 2024-12-31
Aquestive Therapeutics, Inc.
Sympazan, Suboxone, Zuplenz, Azstarys, Libervant, Exservan
Aquestive Therapeutics, Inc. is a pharmaceutical company committed to identifying, developing, and commercializing innovative products to address unmet medical needs, both in the U.S. and globally. It specializes in oral soluble film formulations for various treatments, including neurological conditions and opioid dependence.
Symbol: AQST
Recent Price: $3.52
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Daniel Barber
Sector: Healthcare
Employees: 135
Address: 30 Technology Drive, Warren, NJ 07059
Phone: 908 941 1900
Last updated: 2024-12-31
Celldex Therapeutics, Inc.
therapeutic monoclonal and bispecific antibodies
Celldex Therapeutics is a biopharmaceutical company focused on developing therapeutic monoclonal and bispecific antibodies for treating inflammatory diseases and cancers.
About | About | Management | Directors | About | Contact | About | Contact | Careers | Careers | Careers | Careers | Jobs | Careers | About | About
Symbol: CLDX
Recent Price: $25.12
Industry: Biotechnology
CEO: Mr. Anthony S. Marucci M.B.A.
Sector: Healthcare
Employees: 160
Address: Perryville III Building, Hampton, NJ 08827
Phone: 908 200 7500
Leadership
- Anthony S. Marucci, Founder, President, Chief Executive Officer and Director
- Tibor Keler, Ph.D., Founder, Executive Vice President and Chief Scientific Officer
- Diane C. Young, M.D., Senior Vice President and Chief Medical Officer
- Elizabeth Crowley, Senior Vice President, Chief Product Development Officer
- Sam Martin, Senior Vice President and Chief Financial Officer
- Ronald A. Pepin, Ph.D., Senior Vice President and Chief Business Officer
- Richard Wright, Ph.D., Senior Vice President and Chief Commercial Officer
- Sarah Cavanaugh, Senior Vice President, Corporate Affairs and Administration
- Margo Heath-Chiozzi, M.D., Senior Vice President, Regulatory Affairs
- Freddy A. Jimenez, Esq., Senior Vice President and General Counsel
- Karen L. Shoos, J.D., Former Chair, Director of Operations, Maryland Tech Council Venture Mentoring Services Program
- Keith L. Brownlie, Former Partner, Ernst & Young LLP
- Herbert J. Conrad, Former President, Roche Pharmaceuticals US
- James J. Marino, J.D., Former Partner, Dechert LLP
- Harry H. Penner, Jr., J.D., L.L.M., Former Chairman and CEO, Nascent Bioscience
- Cheryl L. Cohen, President, CLC Consulting; Former Chief Commercial Officer of Medivation, Inc.
- Dr. Garry Neil, Chief Executive Officer; Chair of the Board, Avalo Therapeutics
- Rita Jain, M.D., Former Executive Vice President, Chief Medical Officer of ChemoCentryx, Inc.
- Carl June, M.D.,
- Michel Nussenzweig, M.D., Ph.D.,
- Marc E. Rothenberg M.D., Ph.D.,
- Joseph Schlessinger, Ph.D.,
- Louis Weiner, M.D.,
Last updated: 2024-12-31
Heron Therapeutics, Inc.
SUSTOL, CINVANTI, ZYNRELEF
Heron Therapeutics, Inc. is a biotechnology company focused on developing treatments to address unmet patient needs, utilizing its proprietary Biochronomer drug delivery technology.
About | Management | Directors | About | Contact | Careers | About | Careers | Jobs | Careers
Symbol: HRTX
Recent Price: $1.51
Industry: Biotechnology
CEO: Mr. Craig Alexander Collard
Sector: Healthcare
Employees: 126
Address: 4242 Campus Point Court, San Diego, CA 92121
Phone: 858 251 4400
Leadership
- Adam Morgan, Chairman
- Sharmila Dissanaike, M.D., FACS, FCCM, Director
- Craig Johnson, Lead Independent Director
- Susan Rodriguez, Director
- Christian Waage, Director
- Craig Collard, Director
- Brett Fleshman, Chief Business Officer
Last updated: 2024-12-31
MediciNova, Inc.
MN-166 (ibudilast)
Medici Nova, Inc. is a biopharmaceutical company focused on developing novel therapeutics for serious diseases with unmet medical needs, including neurologic disorders, fibrotic diseases, and solid tumor cancers.
Symbol: MNOV
Recent Price: $2.11
Industry: Biotechnology
CEO: Dr. Yuichi Iwaki M.D., Ph.D.
Sector: Healthcare
Employees: 13
Address: 4275 Executive Square, La Jolla, CA 92037
Phone: 858 373 1500
Leadership
- Yuichi Iwaki, M.D., Ph.D., President and Chief Executive Officer, and Founder
- Kazuko Matsuda, M.D., Ph.D, MPH, Chief Medical Officer
- David H. Crean, Ph.D., Chief Business Officer
- Jason J. Kruger, CPA (inactive), Chief Financial Officer
- Hideki Nagao, Member of the Board of Directors
- Carolyn Beaver, Member of the Board of Directors
- Nicole Lemerond, CFA, Member of the Board of Directors
Last updated: 2024-12-31
Ocean Biomedical, Inc.
Humanized Monoclonal Antibodies, Small Molecule Candidates, Malaria Vaccine
Ocean Biomedical, Inc. is a biopharmaceutical company that develops therapeutic products for oncology, fibrosis, infectious diseases, and inflammation, with a focus on innovative treatments like monoclonal antibodies targeting Chi3l1 and small molecules targeting Chit1.
Symbol: OCEA
Recent Price: $0.60
Industry: Biotechnology
CEO: Dr. Jack A. Elias M.D.
Sector: Healthcare
Employees: 9
Address: Room 325, 55 Claverick Street, Providence, RI 02903
Phone: 401-444-7375
Last updated: 2024-12-31
SAB Biotherapeutics, Inc.
SAB-185, SAB-176
SAB Biotherapeutics is a clinical-stage biopharmaceutical company focusing on developing immunotherapies based on human antibodies, using advanced genetic engineering to produce fully-human polyclonal antibodies targeting diseases such as COVID-19, influenza, autoimmune disorders, and cancer.
Symbol: SABS
Recent Price: $4.15
Industry: Biotechnology
CEO: Mr. Samuel J. Reich
Sector: Healthcare
Employees: 57
Address: 2100 East 54th Street North, Sioux Falls, SD 57104
Phone: 605 679 6980
Last updated: 2024-12-31
Sage Therapeutics, Inc.
ZULRESSO
Sage Therapeutics, Inc. is a biopharmaceutical company that develops and commercializes medicines for central nervous system disorders, with ZULRESSO for postpartum depression and a pipeline including zuranolone and SAGE-324 for various mood and neurological disorders.
About | About | Vision/Values | ESG | Leadership | About | ESG | Contact | Careers | Jobs | About | Careers | Jobs | Jobs | Careers | Culture | Careers | Careers | Careers | Careers | Careers | Locations | Benefits | Careers | DEI | Jobs | Jobs | Site Map | Careers | Careers | About | About | About | About | Jobs | Jobs
Symbol: SAGE
Recent Price: $5.43
Industry: Biotechnology
CEO: Mr. Barry E. Greene
Sector: Healthcare
Employees: 487
Address: 215 First Street, Cambridge, MA 02142
Phone: 617 299 8380
Leadership
- BARRY GREENE, Member of Board of Directors
- CHRIS BENECCHI, Chief Business Officer
- ANNE MARIE COOK, Senior Vice President, General Counsel
- LAURA GAULT, M.D., Ph.D., Chief Medical Officer
- PAMELA HERBSTER, Vice President, Head of People
- KIMI IGUCHI, Chief Financial Officer
- MATT LASMANIS, Chief Technology and Innovation Officer
- MIKE QUIRK, Ph.D., Chief Scientific Officer
- VANESSA PROCTER, Senior Vice President, External Affairs
- AMY SCHACTERLE, Ph.D., Senior Vice President, R&D Strategy and Business Management
- HEINRICH SCHLIEKER, Ph.D., Senior Vice President, Technical Operations
- LIZ BARRETT, President & Chief Executive Officer
- MICHAEL F. COLA,
- JESSICA FEDERER,
- JAMES M. FRATES,
- GENO GERMANO, CHAIR OF THE BOARD
- GEORGE GOLUMBESKI, Ph.D.,
- JEFF JONAS, M.D.,
Last updated: 2024-12-31
Sorrento Therapeutics, Inc.
G-MAB antibody library, Sofusa drug delivery technology, ZTlido
Sorrento Therapeutics, Inc. is a clinical stage and commercial biopharmaceutical company focusing on developing therapies for various diseases, including cancer and autoimmune diseases, using innovative antibody libraries and drug delivery systems.
Symbol: SRNE
Recent Price: $0.00
Industry: Biotechnology
CEO: Dr. Henry H. Ji Ph.D.
Sector: Healthcare
Employees: 949
Address: 4955 Directors Place, San Diego, CA 92121
Phone: 858 203 4100
Last updated: 2024-12-31
TG Therapeutics, Inc.
Ublituximab, Umbralisib, Cosibelimab, TG-1701, TG-1801
TG Therapeutics, Inc. is a commercial stage biopharmaceutical company focused on developing and commercializing novel treatments for B-cell malignancies and autoimmune diseases.
About | About | Leadership | About | About | About | About | Our Story | Contact | Contact | About | About
Symbol: TGTX
Recent Price: $31.45
Industry: Biotechnology
CEO: Mr. Michael S. Weiss Esq.
Sector: Healthcare
Employees: 264
Address: 2 Gansevoort Street, New York, NY 10014
Phone: 212 554 4484
Leadership
- Michael S. Weiss, Chairman, President, and Chief Executive Officer
- Sean A. Power, CPA, Chief Financial Officer
- Adam Waldman, Chief Commercialization Officer
Last updated: 2024-12-31
Vir Biotechnology, Inc.
Sotrovimab (VIR-7832), VIR-2218, VIR-3434, VIR-2482, VIR-1111
Vir Biotechnology, Inc. is a commercial-stage immunology company developing therapeutic products to treat and prevent serious infectious diseases, including COVID-19, hepatitis B, influenza A, and HIV.
Vision/Values | About | Leadership | About | Contact | Contact | Careers | Jobs | About | About
Symbol: VIR
Recent Price: $7.33
Industry: Biotechnology
CEO: Dr. Marianne De Backer M.B.A., M.Sc., Ph.D.
Sector: Healthcare
Employees: 587
Address: 499 Illinois Street, San Francisco, CA 94158
Phone: 415 906 4324
Leadership
- Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer and Director
- Jeff Calcagno, M.D., Executive Vice President and Chief Business Officer
- Vanina de Verneuil, J.D., Executive Vice President, General Counsel and Corporate Secretary
- Mika Kakefuda Derynck, M.D., Executive Vice President, Therapeutic Area Head Oncology
- Mark Eisner, M.D., M.P.H., Executive Vice President and Chief Medical Officer
- Jenny Gumm, Ed.D., MBA, Executive Vice President, Chief Human Resources Officer
- Aine Hanly, Ph.D., Executive Vice President and Chief Technology Officer
- Jason O’Byrne, MBA, Executive Vice President and Chief Financial Officer
- Jennifer Eileen Towne, Ph.D., Executive Vice President and Chief Scientific Officer
- Arran Attridge, Senior Vice President Corporate Communications
- Antonio Lanzavecchia, M.D., Senior Vice President and Senior Research Fellow
- Amalio Telenti, M.D, Ph.D., Executive Vice President and Senior Research Fellow
Last updated: 2024-12-31
XBiotech Inc.
True Human monoclonal antibodies
XBiotech Inc. discovers, develops, and commercializes True Human monoclonal antibodies targeting inflammatory and infectious diseases, with additional development in interleukin-1 alpha therapies for various medical conditions and COVID-19 therapy.
Symbol: XBIT
Recent Price: $4.09
Industry: Biotechnology
CEO: Mr. John Simard
Sector: Healthcare
Employees: 94
Address: 5217 Winnebago Lane, Austin, TX 78744
Phone: 512 386 2900
Last updated: 2024-12-31
Xencor, Inc.
Monoclonal Antibody and Cytokine Therapeutics
Xencor, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery and development of engineered monoclonal antibody and cytokine therapeutics for treating cancer and autoimmune diseases.
About | ESG | Contact | Careers | Careers | About | Events | About | About | About | Contact | Management | About | Directors | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | Careers
Symbol: XNCR
Recent Price: $23.71
Industry: Biotechnology
CEO: Dr. Bassil I. Dahiyat Ph.D.
Sector: Healthcare
Employees: 280
Address: 111 West Lemon Avenue, Monrovia, CA 91016
Phone: 626 305 5900
Last updated: 2024-12-31
Y-mAbs Therapeutics, Inc.
DANYELZA
Y-m Abs Therapeutics, Inc., is a commercial-stage biopharmaceutical company focused on developing and commercializing novel antibody-based therapeutic products for cancer treatment in the United States.
Symbol: YMAB
Recent Price: $7.76
Industry: Biotechnology
CEO: Mr. Michael Rossi
Sector: Healthcare
Employees: 100
Address: 230 Park Avenue, New York, NY 10169
Phone: 646 885 8505
Leadership
- Michael Rossi, President and Chief Executive Officer
- Thomas Gad, Founder, Vice Chairman of the Board of Directors, Chief Business Officer
- Torben Lund-Hansen, SVP, Chief Technical Officer
- Peter Pfreundschuh, Chief Financial Officer
- Vignesh Rajah, SVP, Chief Medical Officer
- Joris Wilms, SVP, Chief Operating Officer
- Sue Smith, SVP, Chief Commercial Officer
- Norman LaFrance, Chief Development Officer
- Johan Wedell-Wedellsborg, Chairman
- Ashutosh Tyagi, M.D.,
- James I. Healy, Chairman
- David N. Gill,
- Laura J. Hamill,
- Mary Tagliaferri, M.D.,
Last updated: 2024-12-31
Galecto, Inc.
GB2064
Galecto, Inc. is a clinical-stage biotechnology company focused on developing molecules for the treatment of fibrosis, cancer, inflammation, and related diseases. Their lead product candidate, GB2064, is in Phase IIa for myelofibrosis. The company also advances other candidates targeting severe fibrotic lung diseases and cancer.
Symbol: GLTO
Recent Price: $4.60
Industry: Biotechnology
CEO: Dr. Hans T. Schambye M.D., Ph.D.
Sector: Healthcare
Employees: 13
Address: 75 State Street, Boston, MA 02109
Phone: 457 070 5210
Last updated: 2024-12-31